ANNA PORTER: Open Payments
NPI 1205443561 · POST FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$800 in 41 payments from 11 companies in 2025. Trend: 2023 $572 · 2024 $514 · 2025 $800
Food & beverage: $800
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $197 |
| PFIZER INC. | 11 | $174 |
| Otsuka America Pharmaceutical, Inc. | 8 | $166 |
| ABBVIE INC. | 3 | $61 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Novo Nordisk Inc | 2 | $41 |
| Janssen Pharmaceuticals, Inc | 1 | $38 |
| Lilly USA, LLC | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
Products named: CAPLYTA, NURTEC ODT, REXULTI, UBRELVY, TRELEGY ELLIPTA, INVEGA SUSTENNA, ABILIFY MAINTENA, PREVNAR 20.
Industry payments across ID — which companies pay providers there.
